The aims of our study were to evaluate the outcomes after implementation of a prospective clinical decision tree algorithm to determine the optimal route of hysterectomy for benign indications, and evaluate its effect on the rate of vaginal hysterectomies performed at our institution. MATERIALS AND METHODS: A clinical algorithm was created to determine the optimal route of hysterectomy utilizing a patient's history of laparotomy, uterine size, and vaginal access as decision tree branches ( Figure 1 ). Strict exclusion criteria were applied ( Table 1 ). The algorithm was prospectively implemented for benign hysterectomies performed at our institution after November 23, 2015. Seven months of surgical cases were included. Data analyzed included patient demographics, medical, obstetrical and surgical history, lab and pathology results, intraoperative and postoperative events including hospital readmission. Results from a retrospective algorithm applied to data from 2009-2013 previously presented by our group (specifically the adherence to the algorithm when a vaginal route was expected) were compared to the prospective use of an algorithm. RESULTS: A total of 101 hysterectomies met inclusion criteria. The algorithm expected a vaginal hysterectomy in 53 (52.5%) and an examination under anesthesia followed by a vaginal hysterectomy in 27 (26.7%). In total, 80 (79.2%) were assigned an expected vaginal route by the algorithm. Nine cases (8.9%) deviated from the algorithm to a more invasive route (8 robotic when vaginal was expected and 1 abdominal when robotic/laparoscopic was expected). Five cases (5.0%) had a vaginal hysterectomy performed when a robotic/laparoscopic was expected, and therefore not considered deviations from the algorithm. When a vaginal hysterectomy was expected and performed (N ¼ 72/80, 90%), there was 1 intraoperative route conversion (1.4%), 2 intraoperative complications (cystotomy, 2.8%), 1 blood transfusion (1.4%), and 1 intraabdominal abscess requiring readmission (1.4%). When a robotic/laparoscopic hysterectomy was expected and performed (n ¼ 14), the mean uterine weight was 217 grams (SD 186 g; range 55-770 g), 8 (57.1%) had a history of a laparotomy, 11 (78.6%) had a vaginal parity of zero, of which 3 had a total parity of 0 (21.4%). Narrow vaginal caliber preventing a vaginal hysterectomy was only noted in 4 patients. Our retrospective results included an adherence to the algorithm in 74% (551/743) of cases when a vaginal route was expected by the algorithm. The prospective adherence was 90% (72/80) when vaginal hysterectomy was expected. CONCLUSION: When a decision tree algorithm was prospectively used to determine the optimal route of hysterectomy for benign disease, nearly 80% were assigned an expected vaginal route. Prospective use of the algorithm increased the rate of vaginal hysterectomy from an already high 74% to 90% when expected by the algorithm. This algorithm is strong, as 98.6% of those expected to be vaginal were successfully completed with few complications. Prospective use of this algorithm nationally may increase the rate of vaginal hysterectomies and lower health care delivery costs.
OBJECTIVES:
The aims of our study were to evaluate the outcomes after implementation of a prospective clinical decision tree algorithm to determine the optimal route of hysterectomy for benign indications, and evaluate its effect on the rate of vaginal hysterectomies performed at our institution. MATERIALS AND METHODS: A clinical algorithm was created to determine the optimal route of hysterectomy utilizing a patient's history of laparotomy, uterine size, and vaginal access as decision tree branches ( Figure 1 ). Strict exclusion criteria were applied ( Table 1 ). The algorithm was prospectively implemented for benign hysterectomies performed at our institution after November 23, 2015. Seven months of surgical cases were included. Data analyzed included patient demographics, medical, obstetrical and surgical history, lab and pathology results, intraoperative and postoperative events including hospital readmission. Results from a retrospective algorithm applied to data from 2009-2013 previously presented by our group (specifically the adherence to the algorithm when a vaginal route was expected) were compared to the prospective use of an algorithm. RESULTS: A total of 101 hysterectomies met inclusion criteria. The algorithm expected a vaginal hysterectomy in 53 (52.5%) and an examination under anesthesia followed by a vaginal hysterectomy in 27 (26.7%). In total, 80 (79.2%) were assigned an expected vaginal route by the algorithm. Nine cases (8.9%) deviated from the algorithm to a more invasive route (8 robotic when vaginal was expected and 1 abdominal when robotic/laparoscopic was expected). Five cases (5.0%) had a vaginal hysterectomy performed when a robotic/laparoscopic was expected, and therefore not considered deviations from the algorithm. When a vaginal hysterectomy was expected and performed (N ¼ 72/80, 90%), there was 1 intraoperative route conversion (1.4%), 2 intraoperative complications (cystotomy, 2.8%), 1 blood transfusion (1.4%), and 1 intraabdominal abscess requiring readmission (1.4%). When a robotic/laparoscopic hysterectomy was expected and performed (n ¼ 14), the mean uterine weight was 217 grams (SD 186 g; range 55-770 g), 8 (57.1%) had a history of a laparotomy, 11 (78.6%) had a vaginal parity of zero, of which 3 had a total parity of 0 (21.4%). Narrow vaginal caliber preventing a vaginal hysterectomy was only noted in 4 patients. Our retrospective results included an adherence to the algorithm in 74% (551/743) of cases when a vaginal route was expected by the algorithm. The prospective adherence was 90% (72/80) when vaginal hysterectomy was expected. CONCLUSION: When a decision tree algorithm was prospectively used to determine the optimal route of hysterectomy for benign disease, nearly 80% were assigned an expected vaginal route. Prospective use of the algorithm increased the rate of vaginal hysterectomy from an already high 74% to 90% when expected by the algorithm. This algorithm is strong, as 98.6% of those expected to be vaginal were successfully completed with few complications. Prospective use of this algorithm nationally may increase the rate of vaginal hysterectomies and lower health care delivery costs. OBJECTIVES: Hysterectomies are among one of the most common major surgical procedures performed in women. However, little is known regarding contemporary U.S. hysterectomy trends for women with benign disease with respect to both operative technique and perioperative complications. We sought to document these trends and to determine the association between these two factors with patient, surgeon, and hospital characteristics. MATERIALS AND METHODS: Hysterectomies performed for benign indications by generalist gynecologists from 2012-2014 were analyzed in the all-payer Maryland Health Services Cost Review Commission database. We included both open hysterectomies and those performed by minimally invasive surgery (MIS). Perioperative complications were defined using the Agency for Healthcare Research and Quality Patient Safety Indicators. Surgeon hysterectomy volume was analyzed by quartiles (0-5 ¼ very low, 6-10 ¼ low, 11-20 ¼ medium, and 21+ cases ¼ high volume). We utilized negative binomial regression and logistic regression to identify patient, surgeon, and hospital characteristics associated with MIS utilization and perioperative complications, respectively. RESULTS: A total of 5660 hospitalizations were identified during the study period. Most patients (61.5%) had an open hysterectomy; the remaining (38.6%) underwent a MIS procedure (25.1% robotic, 46.6% laparoscopic, and 28.3% vaginal). Most surgeons (68.2%) performed 10 or fewer hysterectomies during the 2+ year study period. 
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Ambar Mehta: Nothing to disclose; Tim Xu: Nothing to disclose; Susan Hutfless: Nothing to disclose; Martin Makary: Nothing to disclose; Abdulrahman Sinno: Nothing to disclose; Edward Tanner: Nothing to disclose; Rebecca Stone: Nothing to disclose; Karen Wang: Nothing to disclose; Amanda Fader: Nothing to disclose. OBJECTIVES: Describe our technique for performing the total vaginectomy and urethral lengthening (tissue rearrangement) and discuss our perioperative experience. MATERIALS AND METHODS: After obtaining IRB approval, a retrospective review was performed assessing the evolution of our surgical techniques and perioperative complications associated with the total vaginectomy and urethral lengthening during GAS. Only patients with a prior hysterectomy and undergoing total vaginectomy and urethral lengthening procedures were included in the study. Patients with a prior urethral prelamination and or lengthening were excluded. Perioperative complications were reviewed. Descriptive statistics were utilized for data analysis. RESULTS: Six transgender men have undergone the total vaginectomy and urethral lengthening at the time of radial forearm free flap phalloplasty. The technique includes: (1) complete excision of posterior and lateral vaginal walls in one block (to be wrapped around a Foley catheter and inlayed within the radial forearm flap for urethral prelamination in 1st stage phalloplasty), (2) anterior vaginal wall is exteriorized and used along with labia minora to lengthen the bulbar urethra, (3) vaginal canal closure, (4) closure of perineum, and (5) cystoscopy and Foley catheter placement (Figure 1) . In all cases, vaginal mucosal grafts were obtained for prelamination and for urethral lengthening. Blood loss was less than 200 mL in all cases. No intraoperative complications ajog.org
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